GBM	Glioblastoma
CNS	Central nervous system
WHO	World health organisation
TME	Tumour microenvironment
ECS	Endocannabinoid system
DNA	Deoxyribonucleic acid
RNA	Ribonucleic acid
BBB	Blood brain barrier
BTB	Brain tumour barrier
ECM	Extracellular matrix
MDSC	Myeloid-derived suppressor cells
TNFα	Tumour necrosis factor alpha
IL-6	Interleukin 6
IL-17	Interleukin 17
LPS	Lipopolysaccharide
p53	Tumour protein 53
CB1-R	Cannabinoid receptor type 1
CB2-R	Cannabinoid receptor type 2
FAAH	fatty acid amide hydrolase
MAGL	Monoacylglycerol lipase
IDH	iso-citrate dehydrogenase
ATRX	ATP-de-136 pendent helicase
H3K27M	Lys-27-Met mutations in histone 3
cIMPACT NOW	Consortium to 164 Inform Molecular and Practical Approaches to CNS Tumour Taxonomy
VEGF	vascular endothelial growth factor
LPS	lipopolysaccharide
GIT	Gastrointestinal tract
MGMT	O6-methylguanine-DNA methyltransferase
GATA6	GATA binding protein 6
CASP8	caspase-8
PI3K	phosphoinositide 3-kinase
Akt	protein kinase
MAPK	mitogen-activated protein kinases
ERK	extracellular signal-regulated kinase
JNK	c-Jun N-terminal kinase
p70S6K	70-kDa ribosomal protein S6 kinase
4EBP1	Eukaryotic initiation factor 4E-binding protein 1
ROS	reactive oxygen species
FAK	focal adhesion kinase
ER	endoplasmic reticulum
TMZ	temozolomide
GSCs	glioblastoma stem cells
TIF	therapeutic impact factor
HA	hyaluronic acid
NPs	nanoparticles
FDA	Food and Drug Administration
LNCs	lipid nanocapsules
BA NPs	betulinic acid nanoparticles
PTEe NPs	poly(thioether-ester) nanoparticles
CN	cannabis extract
Me-PTEe	miniemulsion polymerisation poly(thioether-ester) nanoparticles
Se-PTEe	thiol-ene bulk polymerisation polymerisation poly(thioether-ester) nanoparticles